| 摘要 |
A vaccine against human herpes simplex virus comprises the virus particles of bovine mammalitis virus. The vaccine is prepared by infecting a serum-starved cell line with bovine mammalitis virus, incubating the infected cells in a suitable medium and separating the incubation medium whcih contains the virus particles. The vaccine may comprise either live or inactivated virus particles. |
